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Many studies have shown that myelin in the central
nervous system strongly inhibits the regeneration of
axons, so it comes as a surprise to discover that adult
neurons transplanted into the brain rapidly extend their
axons through myelinated pathways.
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Why do severed axons of the central nervous system
(CNS) fail to regenerate, given that severed axons of the
peripheral nervous system (PNS) rapidly re-extend and
re-innervate their targets [1]? The explanation for this
extraordinary observation is crucial to understanding why
our brains and spinal cords do not repair themselves after
injury. Two general classes of explanation have been put
forth to help account for the remarkable difference in the
ability of CNS and PNS axons to regenerate. There may
be fundamental differences between CNS and PNS
neurons, or between CNS and PNS glia (or both). 
Although it was once believed that CNS neurons intrinsi-
cally lack the ability to regenerate, this view was elegantly
disproved by the experiments of Albert Aguayo and his
colleagues, who showed that at least some retinal ganglion
cells (RGCs) could regenerate their axons through frag-
ments of peripheral nerve grafted into their central path-
ways [2]. Moreover, whereas the peripheral processes of
dorsal root ganglion (DRG) neurons rapidly regenerate
down peripheral nerves when severed, the central
processes of these same neurons are unable to regenerate
into the CNS [1]. These observations suggest that there
may be important differences between the ability of CNS
and PNS glia to support regeneration. In the PNS,
Schwann cells are the main glial cell type, whereas CNS
glia include both astrocytes and oligodendrocytes. 
This possibility has received strong support from the
studies of Schwab and colleagues [3–5], who showed that
oligodendrocytes express membrane proteins of 35 kDa
and 250 kDa that are present in CNS myelin and that
strongly inhibit the growth of axons of cultured DRG
neurons. In the PNS, Schwann cell myelin does not
contain these proteins. The monoclonal antibody IN-1
neutralizes the 35 kDa and 250 kDa CNS myelin mole-
cules and allows axons to grow over the oligodendrocytes
in vitro and, to a lesser degree, in vivo in a cut spinal cord
regeneration model [4,5]. Presumably, these signals would
not be inhibitory to growing axons during development,
either because embryonic neurons lack receptors for these
inhibitory molecules or because normally most oligoden-
drocytes do not develop until after target innervation; in
fact, it has been shown previously that embryonic neurons
transplanted into the CNS can successfully regenerate
their axons down myelinated pathways [6]. 
Thus it now comes as a great surprise to learn that adult
DRG neurons transplanted into myelinated regions of
adult brain can, in fact, rapidly regenerate their axons,
demonstrating that myelinated pathways are permissive
for regeneration after all [7]. When Jerry Silver and his col-
leagues transplanted DRG neurons into the brain, into
either the corpus callosum or the fimbria, they found
axons coursing through the myelin at rates of 1–2 mm per
day [7], a rate equal to that seen during development and
during PNS regeneration. By 6 days after the transplant,
80% of the transplanted axons reaching the midline
extended as far as the contralateral white–grey matter
interface of the rostrum of the corpus callosum, and their
axons were observed to branch into terminal arbors, which
the authors suggested could reflect donor innervation of
host grey matter.
So why weren’t the axons of the DRG neurons inhibited
by myelin-associated inhibitory proteins? One obvious
possibility is that the axons simply avoided them by
migrating along other cell types, such as astrocytes,
instead of along myelin (as shown for neuron A in
Figure 1). In contrast, DRG axons had no astrocyte-medi-
ated bridging path to enable them to avoid oligodendro-
cytes in previous culture studies, because the cultures
lacked astrocytes [8]. The electron microscopic studies
necessary to address this issue have not yet been per-
formed for the present experiments [7]. 
A second possibility is that the axons did extend along the
myelin but were not inhibited because the inhibitory pro-
teins are not normally located in the abaxonal (outer)
myelin surface (neuron B in Figure 1). Another myelin
inhibitory protein, myelin-associated glycoprotein (MAG)
[9,10], is clearly localized primarily adaxonally (next to the
axon); the localization of the IN-1 epitopes within myelin
is not yet known. This is an important possibility, because
many previous experiments demonstrating a myelin inhi-
bition in vivo have involved injuries that disrupted myelin,
possibly exposing normally unexposed inhibitory proteins.
Similarly, in vitro experiments using cultured oligodendro-
cytes or myelin extracts may expose such inhibitors. If
only disrupted and not normal myelin is inhibitory, the
microtransplantation technique of Silver and colleagues
[7] may have avoided exposing such inhibitory cues.
Finally, it is possible that the myelin inhibition was
present in vivo but was outweighed by facilitatory influ-
ences from astrocytes or other cell types (neuron C in
Figure 1). It will be important to distinguish among such
possibilities in future experiments.
If myelin does not inhibit the outgrowth of CNS axons in
vivo, what is responsible for the consistent failure of CNS
regeneration? Astrocytes are present in the CNS but not
the PNS, and could in certain cases inhibit growing axons.
Injury to the CNS is normally accompanied by local acti-
vation of astrocytes, which form thick cellular scars at sites
of traumatic damage that could potentially impede axon
growth [11]. When activated at the site of injury, astro-
cytes upregulate expression of a number of extracellular
matrix molecules including tenascin, keratin, and chon-
droitin sulfate proteoglycans (CSPGs), all of which have
been shown to inhibit growing axons [12]. Both develop-
mentally and in the case of CNS injury, CSPG expression
correlates with the cessation of axon growth and failure to
regenerate [13]. Silver and colleagues found that in the
seven transplanted animals that showed no axon growth
into adjacent host white matter, there was an upregulation
of proteoglycan staining at the boundaries of the trans-
plant [7]. Furthermore, in transplanted animals showing
successful regeneration, axon growth aborted in areas
expressing increased levels of CSPGs. Taken together,
these results suggest that astrocyte-associated extracellular
matrix molecules may play a more significant inhibitory
role in vivo than cell-mediated inhibition by oligodendro-
cytes or myelin. It remains to be explored which CSPGs,
or which other co-localized molecules, are responsible for
restriction in vivo. Robust axonal regeneration of adult
neurons in the presence of bridging pathways that allow
avoidance of reactive astrocytes and disrupted myelin has
also been observed in other recent experiments [14,15].
These new experiments [7] also illustrate the difficulty in
understanding why CNS axons do not regenerate, which is
that the problem is likely to be multifactorial. For instance,
the contribution of intrinsic differences between CNS and
PNS neurons, which has not been addressed in these
experiments, is likely to be important. Even in experi-
ments that have shown successful regeneration of axons in
the CNS when inhibitory influences are lessened, the vast
majority of axons still did not regenerate. Many CNS axons
die when their axons are severed, whereas PNS neurons do
not. Indeed, peripheral nerve grafts may first increase neu-
ronal survival and only then facilitate axonal regeneration.
Consistent with this possibility, grafting a peripheral nerve
into the vitreous of the eye, where it can provide only sur-
vival signals to RGCs, increases the level of RGC regener-
ation [16]. Likewise, when the survival of a population of
central neurons (RGCs) was promoted by transgenic over-
expression of the anti-apoptotic protein Bcl-2, their ability
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Figure 1
How did adult DRG neurons regenerate their
axons along myelinated CNS pathways in
vivo? Perhaps (as indicated by neuron A)
DRG axons grew along cell types other than
oligodendrocytes — such as astrocytes; or (as
for neuron B) myelin-associated inhibitors
(brown pyramids) might be masked in non-
disrupted tissues if they are normally
expressed next to the axons only; or finally,
(for neuron C) facilitatory factors may be
sufficient in vivo to overcome other exposed
inhibitory epitopes (pink cubes).
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to regenerate was significantly improved [17]. The rela-
tively lower ability of CNS neurons to regenerate may thus
reflect, in part, that the signals necessary to promote the
survival and growth of many types of CNS and PNS
neurons are fundamentally different [18].
Thus, the Silver lab’s use of DRG neurons [7] was a bril-
liant choice: given that adult DRG neurons promote their
own survival with autocrine signals [19], extrinsic influ-
ences on axonal growth could be investigated without
issues of neuronal survival confounding the results. If an
intrinsic difference in survival control is a major contributor
to the failure of CNS axon regeneration, experiments using
CNS cell populations may not be comparable, and solving
the problem of DRG growth in CNS tissues may not fully
address the issues involved in solving the regeneration
problem in other neuronal populations. Thus, it will be of
great interest in future experiments to examine whether
adult CNS neurons that overexpress Bcl-2 have a similarly
improved capacity for regeneration when transplanted into
CNS myelinated pathways. In any case, the exciting new
experiments of Silver and his colleagues [7] suggest that
although myelin exerts a powerful inhibitory influence in
vitro, the problems of promoting axonal regeneration in
vivo will probably not prove to be insurmountable.
References
1. Ramon y Cajal S: Degeneration and Regeneration of the Nervous
System. Edited by May RM: Oxford University Press: London;
1928.
2. Bray GM, Villegas-Perez MP, Vidal-Sanz M, Carter DA, Aguayo AJ:
Neuronal and nonneuronal influences on retinal ganglion cell
survival, axonal regrowth, and connectivity after axotomy. Ann NY
Acad Sci 1991, 633:214-228.
3. Caroni P, Schwab ME: Two membrane protein fractions from rat
central myelin with inhibitory properties for neurite growth and
fibroblast spreading. J Cell Biol 1988, 106:1281-1288.
4. Schnell L, Schwab ME: Axonal regeneration in the rat spinal cord
produced by an antibody against myelin-associated neurite
growth inhibitors. Nature 1990, 343:269-272.
5. Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, Gao D, Schwab
ME: Recovery from spinal cord injury mediated by antibodies to
neurite growth inhibitors. Nature 1995, 378:498-501.
6. Davies SJ, Field PM, Raisman G: Long fibre growth by axons of
embryonic mouse hippocampal neurons microtransplanted into
the adult rat fimbria. Eur J Neurosci 1993, 5:95-106.
7. Davies SJ, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J:
Regeneration of adult axons in white matter tracts of the central
nervous system. Nature 1997, 390:680-683.
8. Schwab ME, Caroni P: Oligodendrocytes and CNS myelin are
nonpermissive substrates for neurite growth and fibroblast
spreading in vitro. J Neurosci 1988, 8:2381-2393.
9. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT: A
novel role for myelin-associated glycoprotein as an inhibitor of
axonal regeneration. Neuron 1994, 13:757-767.
10. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE:
Identification of myelin-associated glycoprotein as a major myelin-
derived inhibitor of neurite growth. Neuron 1994, 13:805-811.
11. Bignami A, Dahl D: Gliosis. In Neuroglia. Edited by Kettenmann H,
Ransom B: Oxford University Press: New York; 1995.
12. Canning DR, Hoke A, Malemud CJ, Silver J: A potent inhibitor of
neurite outgrowth that predominates in the extracellular matrix of
reactive astrocytes. Int J Dev Neurosci 1996, 14:153-175.
13. McKeon RJ, Schreiber RC, Rudge JS, Silver J: Reduction of neurite
outgrowth in a model of glial scarring following CNS injury is
correlated with the expression of inhibitory molecules on reactive
astrocytes. J Neurosci 1991, 11:3398-3411.
14. Cheng H, Cao Y, Olson L: Spinal cord repair in adult paraplegic
rats: partial restoration of hind limb function. Science 1996,
273:510-513.
15. Li Y, Field PM, Raisman G: Repair of adult rat corticospinal tract by
transplants of olfactory ensheathing cells. Science 1997,
277:2000-2002.
16. Berry M, Carlile J, Hunter A: Peripheral nerve explants grafted into
the vitreous body of the eye promote the regeneration of retinal
ganglion cell axons severed in the optic nerve. J Neurocytol 1996,
25:147-170.
17. Chen DF, Schneider GE, Martinou JC, Tonegawa S: Bcl-2 promotes
regeneration of severed axons in mammalian CNS. Nature 1997,
385:434-439.
18. Meyer-Franke A, Kaplan MR, Pfrieger FW, Barres BA:
Characterization of the signaling interactions that promote the
survival and growth of developing retinal ganglion cells in culture.
Neuron 1995, 15:805-819.
19. Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani
A, Squinto SP, Yancopoulos GD, Lindsay RM: A BDNF autocrine
loop in adult sensory neurons prevents cell death. Nature 1995,
374:450-453.
